According to our latest research, the Global Grid-Forming STATCOM market size was valued at $1.2 billion in 2024 and is projected to reach $4.8 billion by 2033, expanding at a robust CAGR of 16.5% during the forecast period of 2025–2033. The primary driver propelling this impressive growth is the accelerating demand for grid stability solutions amid the rapid integration of renewable energy sources worldwide. https://researchintelo.com/rep....ort/grid-forming-sta

According to our latest research, the global prosthetic joint infections treatment market size reached USD 2.59 billion in 2025, reflecting the growing incidence of joint replacement procedures and subsequent infection risks worldwide. The market is expanding at a robust CAGR of 7.6% and is forecasted to reach approximately USD 5.02 billion by 2034. This growth is primarily propelled by the increasing prevalence of prosthetic joint surgeries,https://growthmarketreports.co....m/report/prosthetic-

According to our latest research, the global Jacking Machines market size reached USD 5.78 billion in 2025, reflecting robust demand across key end-use industries. The market is projected to expand at a CAGR of 5.6% from 2026 to 2034, reaching an estimated USD 9.49 billion by 2034. This sustained growth is primarily driven by increasing infrastructure development, heightened investments in construction and mining, and the ongoing modernization of industrial operations worldwide.https://growthmarketreports.co....m/report/jacking-mac

The global oral GLP-1 obesity drug market was valued at $135.0 billion in 2025 and is projected to surge to $631.2 billion by 2034, registering an exceptional compound annual growth rate of 18.5% over the forecast period 2026-2034, cementing its position as one of the most transformative therapeutic segments in modern pharmaceutical history. This market encompasses all orally administered glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapies specifically indicated or in advanced https://researchintelo.com/rep....ort/oral-glp-1-obesi

The global gene therapy for rare pediatric immune deficiencies (Leukocyte Adhesion Deficiency Type I) market was valued at approximately $0.6 billion in 2025 and is projected to grow to $3.8 billion by 2034, expanding at a robust compound annual growth rate (CAGR) of 22.8% over the forecast period 2026-2034. This ultra-orphan segment represents one of the most concentrated and scientifically advanced niches within the broader gene therapy landscape, anchored by the landmark regulatory https://researchintelo.com/rep....ort/gene-therapy-for